Hot Pursuit     16-Apr-24
Caplin Point rises on USFDA nod for eye drops
Caplin Point Laboratories added 1.67% to Rs 1,318.75 after its subsidiary, Caplin Steriles received final approval from the US drug regulator for its abbreviated new drug application (ANDA) Ofloxacin Ophthalmic Solution.
The approved ANDA is a generic therapeutic equivalent version of reference listed drug (RLD), Ocuflox Ophthalmic Solution of Allergan Inc.

Ofloxacin Ophthalmic Solution (eye drops) is indicated for treatment of eye infections caused during the conditions of conjunctivitis and corneal ulcers.

According to IQVIA (IMS Health), Ofloxacin Ophthalmic Solution had US sales of approximately $52 million for the 12- month period ending December 2023.

Caplin Point Laboratories is a fast-growing pharmaceutical company with a unique business model catering predominantly to emerging markets of Latin America and Africa. The company has manufacturing facilities that cater to a complete range of finished dosage forms.

The company‘s consolidated net profit jumped 30.1% to Rs 119.82 crore on 17% increase in revenue from operations to Rs 435.50 crore in Q3 FY24 over Q3 FY23.

Previous News
  Caplin Point Laboratories fixes record date for final dividend
 ( Market Beat - Reports 05-Sep-22   12:58 )
  Caplin Point Laboratories to convene board meeting
 ( Corporate News - 28-Oct-21   11:08 )
  Caplin Point jumps after Q3 PAT rises 30% YoY to Rs 120 cr
 ( Hot Pursuit - 12-Feb-24   12:46 )
  Caplin Point Laboratories consolidated net profit rises 19.12% in the March 2022 quarter
 ( Results - Announcements 12-May-22   13:49 )
  Board of Caplin Point Laboratories accepts cessation of director
 ( Corporate News - 05-Sep-22   13:21 )
  Caplin Point Laboratories consolidated net profit rises 27.78% in the December 2019 quarter
 ( Results - Announcements 05-Feb-20   14:59 )
  Caplin Point Laboratories to convene AGM
 ( Corporate News - 12-Sep-18   09:48 )
  Caplin Sterlies receives USFDA final approval for Sumatriptan Injection
 ( Corporate News - 14-Jul-21   13:39 )
  Caplin Point Laboratories consolidated net profit rises 17.18% in the December 2014 quarter
 ( Results - Announcements 04-Feb-15   18:31 )
  Caplin Point Laboratories allots 11,666 equity shares under ESOP
 ( Corporate News - 12-May-22   15:35 )
  Caplin Point Laboratories consolidated net profit rises 58.72% in the September 2017 quarter
 ( Results - Announcements 09-Nov-17   16:56 )
Other Stories
  Welspun Investments & Commercials Ltd leads losers in 'B' group
  11-Feb-25   14:45
  Volumes soar at CRISIL Ltd counter
  11-Feb-25   14:30
  Cera Sanitaryware declines as Q3 PAT slips 10% YoY to Rs 46 cr
  11-Feb-25   14:30
  Real Estate shares fall
  11-Feb-25   14:00
  Industrials shares fall
  11-Feb-25   14:00
  Healthcare shares fall
  11-Feb-25   14:00
  Patanjali Foods Q3 PAT climbs 71% YoY to Rs 371 cr
  11-Feb-25   13:48
  State Bank of India eases for fifth straight session
  11-Feb-25   13:35
  Bosch Ltd drops for fifth straight session
  11-Feb-25   13:35
  Power Grid Corporation of India Ltd eases for fifth straight session
  11-Feb-25   13:35
Back Top